Longeveron Inc. Amends S-1 Registration Filing

TL;DR

Longeveron S-1/A filed - looks like they're still trying to get shares out.

AI Summary

Longeveron Inc. filed an S-1/A amendment on May 21, 2024, related to its registration statement (No. 333-278995). The company, based in Miami, Florida, is involved in pharmaceutical preparations, specifically in the field of regenerative medicine. This filing is an amendment to a previous registration, indicating ongoing efforts to potentially offer securities to the public.

Why It Matters

This amendment to Longeveron's S-1 filing suggests the company is continuing its process to potentially raise capital or offer shares, which could impact its future operations and stock performance.

Risk Assessment

Risk Level: medium — S-1/A filings often indicate a company is seeking to raise capital, which can be a sign of financial need or growth ambitions, carrying inherent investment risks.

Key Numbers

• 333-278995 — Registration Number (Identifies the specific SEC registration statement being amended.)

Key Players & Entities

• Longeveron Inc. (company) — Registrant
• 333-278995 (dollar_amount) — Registration Number
• May 21, 2024 (date) — Filing Date
• Miami, Florida (location) — Company Headquarters
• Wa'el Hashad (person) — Chief Executive Officer

FAQ

Key Financial Figures

• $0.001 — of our Class A Common Stock, par value $0.001 per share ("Class A common stock") issu
• $11.8 million — receive proceeds of up to approximately $11.8 million if all of the Warrants covered by this
• $1.75 — ported on the NASDAQ Capital Market was $1.75 per share. Investing in our securities
• $1.235 b — total annual gross revenues of at least $1.235 billion, (3) the date on which we are dee
• $700.0 million — n stock held by non-affiliates exceeded $700.0 million as of the last business day of our most
• $1.0 billion — date on which we have issued more than $1.0 billion in non-convertible debt securities duri
• $250.0 million — o long as our public float is less than $250.0 million measured on the last business day of ou
• $100.0 million — ter, or our annual revenue is less than $100.0 million during the most recently completed fisc
• $700.0 million — year and our public float is less than $700.0 million measured on the last business day of ou

Filing Documents

• ea0206591-s1a1_longeveron.htm (S-1/A) — 395KB
• ea020659101ex23-1_longeveron.htm (EX-23.1) — 2KB
• image_001.jpg (GRAPHIC) — 8KB
• image_002.jpg (GRAPHIC) — 1KB
• image_003.jpg (GRAPHIC) — 1KB
• image_004.jpg (GRAPHIC) — 1KB
• 0001213900-24-045580.txt ( ) — 590KB
• lgvn-20240331.xsd (EX-101.SCH) — 3KB
• lgvn-20240331_def.xml (EX-101.DEF) — 6KB
• lgvn-20240331_lab.xml (EX-101.LAB) — 9KB
• lgvn-20240331_pre.xml (EX-101.PRE) — 6KB
• ea0206591-s1a1_longeveron_htm.xml (XML) — 2KB

RISK FACTORS

RISK FACTORS 14 DIVIDEND POLICY 21

USE OF PROCEEDS

USE OF PROCEEDS 21 DETERMINATION OF OFFERING PRICE 22 THE SELLING STOCKHOLDERS 22 PLAN OF DISTRIBUTION 26

DESCRIPTION OF SECURITIES TO BE REGISTERED

DESCRIPTION OF SECURITIES TO BE REGISTERED 27 LEGAL MATTERS 29 EXPERTS 29 WHERE YOU CAN FIND MORE INFORMATION 29 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 30 i ABOUT THIS PROSPECTUS This prospectus provides you with a general description of the Class A common stock that may be resold by the Selling Stockholders. In certain circumstances, we may provide a prospectus supplement that will contain specific information about the terms of a particular offering by the Selling Stockholders. We also may provide a prospectus supplement to add information to, or update or change information contained in, this prospectus. To the extent there is a conflict between the information contained in this prospectus and any prospectus supplement, you should rely on the information in the prospectus supplement, provided that if any statement in one of these documents is inconsistent with a statement in another document having a later date—for example, a document incorporated by reference in this prospectus or any prospectus supplement—the statement in the later-dated document modifies or supersedes the earlier statement. This prospectus is part of a registration statement that we have filed with the Securities and Exchange Commission pursuant to which the Selling Stockholders named herein may, from time to time, offer and sell or otherwise dispose of the Class A common stock covered by this prospectus. You should rely only on the information contained in this prospectus or any related prospectus supplement. We have not authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. The information contained in this prospectus is accurate only on the date of this prospectus. Our business, financial condition, results of operations and prospects may have changed since such date. Other than as required under the federal securities laws, we undertake no obligation to pub

View Full Filing

View this S-1/A filing on SEC EDGAR